4.7 Article

Identifying hub genes, key pathways and key immune-related genes in Peyronie's disease by integrated bioinformatic analysis

Related references

Note: Only part of the references are listed.
Article Urology & Nephrology

Downregulation of miR-29b is associated with Peyronie's disease

Vinicius Genuino dos Santos et al.

Summary: This study found that the expression of miR-29b is downregulated in the fibrous plaque, tunica albuginea, and corpus cavernosum of patients with PD compared to the control group. This provides evidence for the association between miR-29b and PD.

UROLOGIA JOURNAL (2022)

Review Chemistry, Medicinal

Berberine as a natural modulator of inflammatory signaling pathways in the immune system: Focus on NF-kappa B, JAK/STAT, and MAPK signaling pathways

Saeed Mohammadian Haftcheshmeh et al.

Summary: This review discusses the modulatory effects of berberine (BBR) on various inflammatory signaling pathways in the immune system and explores its therapeutic efficacy and anti-inflammatory effects.

PHYTOTHERAPY RESEARCH (2022)

Review Pharmacology & Pharmacy

Pharmacotherapy in Peyronie's disease: a state-of-the-art review on established contemporary and emerging drugs

Eric Chung et al.

Summary: This article examines the current understanding of established contemporary and emerging pharmacotherapies for Peyronie's disease (PD). The study suggests that combination therapy may be more effective than monotherapy, and a multidisciplinary approach and novel drug targets could provide a more effective treatment paradigm. Understanding the pathophysiology of PD will contribute to the development of future regenerative technologies.

EXPERT OPINION ON PHARMACOTHERAPY (2022)

Review Cell Biology

JAK/STAT: Why choose a classical or an alternative pathway when you can have both?

Lena Puigdevall et al.

Summary: A subset of cytokines triggers the JAK-STAT pathway to exert various functions such as inflammation and immune responses. There are alternative modes of STAT activation, including association between the tyrosine-free region of cytokine receptors and STATs, and direct interaction between JAK and STAT proteins. These noncanonical mechanisms by cytokine receptors suggest their importance and are discussed in this review.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2022)

Review Pharmacology & Pharmacy

A Comprehensive Overview of Globally Approved JAK Inhibitors

Ahmed M. Shawky et al.

Summary: This review discusses eleven JAK inhibitors that have been approved for clinical use, including their chemical and pharmacological data, inhibitory activities, pharmacological uses, crystal structures, and metabolic pathways and metabolites. This information can contribute to the design of new JAK inhibitors for the treatment of inflammatory and autoimmune diseases.

PHARMACEUTICS (2022)

Article Urology & Nephrology

Tolerance and efficacy of platelet-rich plasma injections in Peyronie's disease: Pilot study

A. Schirmann et al.

Summary: This study suggests that platelet-rich plasma (PRP) injections for the treatment of Peyronie's disease are safe and effective in improving symptoms and erectile function in patients with erectile dysfunction.

PROGRES EN UROLOGIE (2022)

Article Public, Environmental & Occupational Health

Bioinformatics-Based Identification of Potential Hypoxia-Related Genes Associated With Peyronie's Disease

Yuanshan Cui et al.

Summary: This study applied bioinformatic approaches to select candidate hypoxia-related genes involved in the pathogenesis of Peyronie's disease (PD). Further analyses on these genes revealed their potential modulatory functions in glycolysis/gluconeogenesis and carbon metabolism, providing important insights for understanding the pathogenesis of PD.

AMERICAN JOURNAL OF MENS HEALTH (2022)

Article Medicine, Research & Experimental

Role of miRNA and lncRNAs in organ fibrosis and aging

Soudeh Ghafouri-Fard et al.

Summary: Fibrosis is the endpoint of pathological remodeling, with TGF-β, WNT, and YAP/TAZ signaling pathways playing key roles in this process. Long noncoding RNAs and microRNAs participate in organ fibrosis by modulating the activity of related signaling pathways.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Urology & Nephrology

RNA-sequencing profiling analysis of pericyte-derived extracellular vesicle-mimetic nanovesicles-regulated genes in primary cultured fibroblasts from normal and Peyronie's disease penile tunica albuginea

Guo Nan Yin et al.

Summary: The study utilized RNA sequencing technology to investigate potential target genes regulated by pericyte-derived extracellular vesicle-mimetic nanovesicles (PC-NVs) in primary fibroblasts derived from human PD plaque. The results revealed differential gene expression in normal fibroblasts, PD fibroblasts, and PD fibroblasts treated with PC-NVs, highlighting the importance of these validated genes as potential targets for understanding mechanisms and conducting molecular studies in PD.

BMC UROLOGY (2021)

Review Andrology

Evolving therapies for Peyronie's disease: how can we work towards new drugs?

Uros Milenkovic et al.

TRANSLATIONAL ANDROLOGY AND UROLOGY (2020)

Review Urology & Nephrology

Peyronie's disease: Contemporary evaluation and management

Matthew J. Ziegelmann et al.

INTERNATIONAL JOURNAL OF UROLOGY (2020)

Article Urology & Nephrology

Repair of the penile suspensory ligament for congenital and acquired pathology

Oliver Ralph et al.

BJU INTERNATIONAL (2019)

Article Pharmacology & Pharmacy

What role do pharmaceuticals play in the treatment of Peyronie’s disease and is there a need for new emerging drugs?

U Milenkovic et al.

EXPERT OPINION ON EMERGING DRUGS (2019)

Review Cell Biology

An overview of microRNAs: Biology, functions, therapeutics, and analysis methods

Kioomars Saliminejad et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Review Urology & Nephrology

Pathophysiology and Future Therapeutic Perspectives for Resolving Fibrosis in Peyronie's Disease

Uros Milenkovic et al.

SEXUAL MEDICINE REVIEWS (2019)

Article Cell Biology

Negative Regulation of Cytokine Signaling in Immunity

Akihiko Yoshimura et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)

Article Medicine, Research & Experimental

Role of interleukin-6 and pentraxin 3 as an early marker in Peyronie's disease

Arda Atar et al.

KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2017)

Editorial Material Urology & Nephrology

The pathophysiology of Peyronie's disease: beyond the Smith's space

Tulio M. Graziottin

INTERNATIONAL BRAZ J UROL (2015)